­
­
­
­

Inventi Impact: Obstetrics and Gynaecology

Articles

  • Inventi:hog/31731/20
    Sertoli-Leydig Cell Tumor from Latifa Hospital, Dubai UAE: Case Report
    Research 2020 : July - September
    Z Almahloul, A B Fazari, L Paulose, Z Nagshabandi, T Gergawi

    Sertoli-Leydig cell tumors (SLCTs) are rare tumors. Mass and pain are the\npresenting feature. The varying histopathology and differentiation of this\ntumor present difficulties with proper diagnosis and development of optimal\ntreatment regimens. The prognosis depends on tumors grading and staging.\nSurgery is main stay management option. Chemotherapy and radiation options\nare still of choice. We aimed to present Sertoli-Leydig cell tumor managed\nsurgical at Latifa Hospital in Dubai, UAE with acceptable outcome and\ngood patient satisfaction.

    How to Cite this Article
    Attribution/ CC Compliant Citation: Almahloul, Z., Fazari, A.B., Paulose, L., Nagshabandi, Z. and Gergawi, T. (2020) Sertoli-Leydig Cell\nTumor from Latifa Hospital, Dubai UAE: Case Report. Open Journal of Obstetrics and Gynecology , 10, 319-325.\nhttps://doi.org/10.4236/ojog.2020.1020028\nhttp://creativecommons.org/licenses/by/4.0/\n\nSome formatting elements, header, footer, logos, dates and pagination were modified while adapting this article.
    Download Full Text